Chondroitin Sulfate-Modified Liposomes for Targeted Co-Delivery of Doxorubicin and Retinoic Acid to Suppress Breast Cancer Lung Metastasis

Chondroitin Sulfate-Modified Liposomes for Targeted Co-Delivery of Doxorubicin and Retinoic Acid to Suppress Breast Cancer Lung Metastasis

Breast cancer treatment remains challenging due to high levels of cell metastasis. Chemotherapy drug combinations can inhibit both tumor growth in situ and metastasis to distant organs. Therefore, here, we developed chondroitin sulfate liposomes (CSLs) as a carrier for the co-delivery of retinoic ac...

Full description

Bibliographic Details
Main Authors: Zhiwei Zhang, Lixin Ma, Jingwen Luo
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Pharmaceutics
Subjects:
chondroitin sulfate
doxorubicin
retinoic acid
liposomes
breast cancer
Online Access:https://www.mdpi.com/1999-4923/13/3/406

Internet

https://www.mdpi.com/1999-4923/13/3/406

Similar Items